Completed OBSERVATIONAL NCT04515589

Central Aspects of Pain in Rheumatoid Arthritis (CAP-RA)

Sponsor: Pfizer

Updated 10 times since 2020 Last updated: Nov 28, 2023 Started: Aug 11, 2021 Primary completion: Sep 30, 2023 Completion: Sep 30, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Rheumatoid Arthritis, this trial is completed. The trial is conducted by Pfizer and has accumulated 10 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2024 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
Jul 2022 — Jan 2024 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Dec 2021 — Jul 2022 [monthly]

Not Yet Recruiting

▶ Show 5 earlier versions

Sep 2021 — Dec 2021 [monthly]

Not Yet Recruiting
Jan 2021 — Sep 2021 [monthly]

Not Yet Recruiting
Dec 2020 — Jan 2021 [monthly]

Not Yet Recruiting
Nov 2020 — Dec 2020 [monthly]

Not Yet Recruiting
Sep 2020 — Nov 2020 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Pfizer
University of Nottingham
Versus Arthritis

Data source: University of Nottingham

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mansfield, United Kingdom